1445901-75-6

Basic information

• Product Name: N-[4-(4-acetyl-piperazin-1-yl)-2-fluoro-benzyl]-N-cyclobutyl-1-(4-fluorophenyl)-methanesulfonamide
• CAS NO: 1445901-75-6
• Molecular Weight: 477.575
• Mol File: 1445901-75-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[4-(4-acetyl-piperazin-1-yl)-2-fluoro-benzyl]-N-cyclobutyl-1-(4-fluorophenyl)-methanesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[4-(4-acetyl-piperazin-1-yl)-2-fluoro-benzyl]-N-cyclobutyl-1-(4-fluorophenyl)-methanesulfonamide(1445901-75-6)
• EPA Substance Registry System: N-[4-(4-acetyl-piperazin-1-yl)-2-fluoro-benzyl]-N-cyclobutyl-1-(4-fluorophenyl)-methanesulfonamide(1445901-75-6)

Safety Data

• Hazardous Substances Data: 1445901-75-6(Hazardous Substances Data)

Upstream product

• 1445902-92-0 4-(4-acetylpiperazin-1-yl)-2-fluorobenzaldehyde 
• 1445902-93-1 1-(4-(4-((cyclobutylamino)methyl)-3-fluorophenyl)piperazin-1-yl)ethanone 
• 103360-04-9 4-fluorobenzylsulfonyl chloride 
• 439814-87-6 4-bromo-1-(dimethoxymethyl)-2-fluorobenzene 
• 13889-98-0 N-acetylpiperidine 

Relevant articles and documents

Minor structural change to tertiary sulfonamide RORC ligands led to opposite mechanisms of action

A minor structural change to tertiary sulfonamide RORc ligands led to distinct mechanisms of action. Co-crystal structures of two compounds revealed mechanistically consistent protein conformational changes. Optimized phenylsulfonamides were identified as RORc agonists while benzylsulfonamides exhibited potent inverse agonist activity. Compounds behaving as agonists in our biochemical assay also gave rise to an increased production of IL-17 in human PBMCs whereas inverse agonists led to significant suppression of IL-17 under the same assay conditions. The most potent inverse agonist compound showed >180-fold selectivity over the ROR isoforms as well as all other nuclear receptors that were profiled.